Detalhe da pesquisa
1.
Impaired GABAergic regulation and developmental immaturity in interneurons derived from the medial ganglionic eminence in the tuberous sclerosis complex.
Acta Neuropathol
; 147(1): 80, 2024 05 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38714540
2.
Lipid mediator n-3 docosapentaenoic acid-derived protectin D1 enhances synaptic inhibition of hippocampal principal neurons by interaction with a G-protein-coupled receptor.
FASEB J
; 36(3): e22203, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35188290
3.
A systems-level analysis highlights microglial activation as a modifying factor in common epilepsies.
Neuropathol Appl Neurobiol
; 48(1): e12758, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34388852
4.
An Unbalanced Synaptic Transmission: Cause or Consequence of the Amyloid Oligomers Neurotoxicity?
Int J Mol Sci
; 22(11)2021 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34206089
5.
Phytocannabinoids in Neurological Diseases: Could They Restore a Physiological GABAergic Transmission?
Int J Mol Sci
; 21(3)2020 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31979108
6.
Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy.
Proc Natl Acad Sci U S A
; 113(11): 3060-5, 2016 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26929355
7.
A novel action of lacosamide on GABAA currents sets the ground for a synergic interaction with levetiracetam in treatment of epilepsy.
Neurobiol Dis
; 115: 59-68, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29621596
8.
A novel GABAergic dysfunction in human Dravet syndrome.
Epilepsia
; 59(11): 2106-2117, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30306542
9.
Neuroinflammatory targets and treatments for epilepsy validated in experimental models.
Epilepsia
; 58 Suppl 3: 27-38, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28675563
10.
Functional aspects of early brain development are preserved in tuberous sclerosis complex (TSC) epileptogenic lesions.
Neurobiol Dis
; 95: 93-101, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27425893
11.
Pharmacological modulation in mesial temporal lobe epilepsy: Current status and future perspectives.
Pharmacol Res
; 113(Pt A): 421-425, 2016 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-27659220
12.
GABAA currents are decreased by IL-1ß in epileptogenic tissue of patients with temporal lobe epilepsy: implications for ictogenesis.
Neurobiol Dis
; 82: 311-320, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26168875
13.
Physiological characterization of human muscle acetylcholine receptors from ALS patients.
Proc Natl Acad Sci U S A
; 108(50): 20184-8, 2011 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-22128328
14.
Membranes and Synaptosomes Used to Investigate Synaptic GABAergic Currents in Epileptic Patients.
Membranes (Basel)
; 14(3)2024 Mar 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38535283
15.
Fractalkine/CX3CL1 modulates GABAA currents in human temporal lobe epilepsy.
Epilepsia
; 54(10): 1834-44, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24032743
16.
Enhancement of GABA(A)-current run-down in the hippocampus occurs at the first spontaneous seizure in a model of temporal lobe epilepsy.
Proc Natl Acad Sci U S A
; 107(7): 3180-5, 2010 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-20133704
17.
Traditional and Innovative Anti-seizure Medications Targeting Key Physiopathological Mechanisms: Focus on Neurodevelopment and Neurodegeneration.
Curr Neuropharmacol
; 21(8): 1736-1754, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37143270
18.
Immune-mediated myogenesis and acetylcholine receptor clustering promote a slow disease progression in ALS mouse models.
Inflamm Regen
; 43(1): 19, 2023 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36895050
19.
Intranasal Administration of KYCCSRK Peptide Rescues Brain Insulin Signaling Activation and Reduces Alzheimer's Disease-like Neuropathology in a Mouse Model for Down Syndrome.
Antioxidants (Basel)
; 12(1)2023 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36670973
20.
Riluzole blocks human muscle acetylcholine receptors.
J Physiol
; 590(10): 2519-28, 2012 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22431338